QI
MRNA icon

Qtron Investments’s Moderna MRNA Stock Holding History

Qtron Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,030
Closed -$544K – 438
2022
Q4 		$544K Buy
3,030
+301
+11% +$49.2K 0.11% 249
2022
Q3 		$323K Buy
2,729
+698
+34% +$106K 0.08% 317
2022
Q2 		$290K Hold
2,031
– – 0.06% 337
2022
Q1 		$350K Hold
2,031
– – 0.08% 278
2021
Q4 		$516K Sell
2,031
-1,636
-45% -$478K 0.12% 235
2021
Q3 		$1.41M Sell
3,667
-2,238
-38% -$825K 0.38% 58
2021
Q2 		$1.39M Hold
5,905
– – 0.35% 55
2021
Q1 		$773K Hold
5,905
– – 0.22% 117
2020
Q4 		$617K Buy
5,905
+966
+20% +$97.7K 0.17% 155
2020
Q3 		$349K Buy
+4,939
New +$344K 0.12% 207

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Qtron Investments's MRNA Position: Q1 2023 in Review

Qtron Investments sold out of Moderna (MRNA) in Q1 2023, closing a stake of 3,030 shares — an estimated $544K sold.

Qtron Investments first reported a position in MRNA in Q3 2020 and held it in 10 quarters. The position peaked at $1.41M in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Qtron Investments reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Qtron Investments sold 3,030 Moderna shares in Q1 2023, an estimated $544K.
  • Qtron Investments first reported a position in Moderna in Q3 2020 and held it in 10 quarters.
  • Qtron Investments's Moderna position peaked at $1.41M in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Qtron Investments's 13F filing for Q1 2023, filed 11 May 2023.